Viking Therapeutics Projects Earnings Loss Amid Market Concerns

San Diego, Saturday, 18 October 2025.
Viking Therapeutics anticipates a significant Q3 earnings loss, impacting investor confidence. The stock fell 3.46% on 17 October 2025, with future strategic directions now under scrutiny.